Companies
Sartorius
STOXX 600Health Care· Germany

SRTX

Status-Quo-Player

Sartorius

$180.00

+5.02%

Open $176.40·Prev $171.40

Delayed

STATUS-QUO-PLAYER

Power Core

Sartorius locks in customers through validated single-use bioprocess systems that become regulatory fixtures in drug manufacturing.

Published14 Apr 2026
UniverseSTOXX 600
SectorHealth Care

Direction of Movement

upward

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.